A Medical Device Daily

Boston Scientific (Natick, Massachusetts) reported the launch of the platinum chromium Taxus Element Paclitaxel-Eluting coronary stent system in select markets worldwide. The Taxus Element stent features a new platinum chromium alloy engineered specifically for coronary stent applications.

The platinum chromium alloy used in the Element stent system was engineered specifically for coronary stenting, delivering both strength and flexibility. The Element stent system platform also features a new stent architecture with thinner struts, increased flexibility and a lower profile, designed to improve radial strength, recoil and angiographic visibility.

The Element series consists of three distinct versions: the Paclitaxel-Eluting Taxus Element Stent, the Everolimus-Eluting Promus Element Stent and the bare-metal Element Stent. Boston Scientific says all three versions of the Element Stent are built on the platinum chromium platform and are designed to provide interventional cardiologists improved performance in treating patients with complex coronary artery disease.